INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 16 filers reported holding INTEC PHARMA LTD JERUSALEM in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,559,000 | -80.6% | 820,000 | -67.2% | 0.12% | -84.5% |
| Q1 2019 | $18,325,000 | -2.8% | 2,500,000 | 0.0% | 0.79% | -29.7% |
| Q4 2018 | $18,850,000 | +29.8% | 2,500,000 | -2.8% | 1.13% | +69.0% |
| Q3 2018 | $14,524,000 | +28.4% | 2,570,705 | 0.0% | 0.67% | +53.3% |
| Q2 2018 | $11,311,000 | -18.9% | 2,570,705 | +17.1% | 0.44% | -34.7% |
| Q1 2018 | $13,943,000 | +23.3% | 2,195,705 | 0.0% | 0.67% | -9.1% |
| Q4 2017 | $11,308,000 | -42.5% | 2,195,705 | 0.0% | 0.73% | -51.9% |
| Q3 2017 | $19,652,000 | – | 2,195,705 | – | 1.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 630,000 | $3,528,000 | 1.74% |
| DAFNA Capital Management LLC | 135,000 | $756,000 | 0.75% |
| Cormorant Asset Management, LP | 800,000 | $4,480,000 | 0.72% |
| Perceptive Advisors | 700,000 | $3,920,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 613,910 | $3,438,000 | 0.14% |
| Ion Asset Management Ltd. | 10,000 | $56,000 | 0.08% |
| JANE STREET GROUP, LLC | 34,317 | $194,000 | 0.00% |
| UBS Group AG | 1,296 | $7,000 | 0.00% |